Increasing Health Access Through Telemedicine

A new digital health platform could make it easier for people with cancer, diabetes and other non-communicable diseases to access care.

Known as All-in-ONE, this digital health platform was developed to improve patient follow-up and care, specifically with NCD patients in mind. The platform, developed by the Pan American Health Organization, aims to help to address barriers to care for patients living in remote areas in particular.  

Overcoming Barriers to Care 

Long distances required to reach a clinician office often mean that patients cannot come in as often as needed or stop seeking care altogether. And that’s a problem for patients with many non-communicable diseases. The chronic nature of these conditions requires consistent monitoring and follow up care to ensure that symptoms are managed, or disease progression is stalled. 

The new platform supports, among other capabilities:  

  • Trainings for health care professionals  
  • Instant messaging 
  • Digital prescribing 

The All-in-ONE platform is meant to allow patients access to the health system and care in ways that previously may have been unavailable or nonexistent.  

The platform also offers assistance for clinicians in formulating the best treatment plans for their patients, whether that be a fully virtual format or a hybrid format that combines in-person consultations with telemedicine visits. 

The Impact of NCDs 

Non-communicable diseases are the leading cause of death and disability across the globe, accounting for about 71% of all worldwide deaths. Non-communicable diseases include diseases such as cancer, cardiovascular disease, diabetes, and chronic lung diseases. They often stem from genetic, physiological, environmental or behavioral factors.  

The COVID-19 pandemic showed the world how telehealth can increase access to health care for patients across the globe. Now the new All-in-ONE digital health platform shows how incorporating telemedicine into health systems can help to fill access gaps. With any luck, the platform can also further the international community’s goal of reducing premature mortality from NCDs by one third by 2030.